ANIXA BIOSCIENCES, INC. Fair Value of Long-Term Debt
ANIXA BIOSCIENCES, INC. (ANIX) had Fair Value of Long-Term Debt of $1.76 million as of 2013-04-30, per its 10-Q/A filed 2013-06-19.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2013-06-19
- 2013-04-30: Long-term Debt, Fair Value $1.76M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2013-04-30 | $1.76M 10-Q/A · filed 2013-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |